Victrex plc
VCT · Main Market · Chemicals · mcap £821m · 926.0p
| Date | Type | Announcement | Day |
|---|---|---|---|
| 05 Oct 26 | Holding | Holding(s) in Company | |
| 30 Sep 26 | Routine | Total Voting Rights | |
| 24 Sep 26 | Capital Markets Event
Victrex outlines five-year transformation strategy targeting mid-single digit revenue growth, 50% gross margin and £250m cumulative free cash flow by FY31. |
−10.4% | |
| 18 Sep 26 | Holding | Holding(s) in Company | |
| 09 Sep 26 | Trading update | Pre-Close Trading Update
Underlying PBT upgraded to £45m-£47m from £42m-£44m; Kleiss Gears disposal completed. |
+16.2% |
| 28 Aug 26 | Routine | Total Voting Rights | |
| 31 Jul 26 | Routine | Total Voting Rights | |
| 24 Jul 26 | Holding | Holding(s) in Company | |
| 24 Jul 26 | Board change | Directorate Change
CFO Ian Melling to step down on 31 July. Four executives leaving, two new Executive Committee members appointed. |
+3.2% |
| 20 Jul 26 | Holding | Holding(s) in Company | |
| 07 Jul 26 | Trading update | Trading Statement
Q3 revenue grew 18% year-on-year driven by volumes; full-year guidance maintained at £42m-£44m underlying PBT. |
+16.3% |
| 02 Jul 26 | Routine | Block Listing Application | |
| 30 Jun 26 | Routine | Total Voting Rights | |
| 30 Jun 26 | Holding | Holding(s) in Company | |
| 29 May 26 | Routine | Total Voting Rights | |
| 18 May 26 | Board change | Directorate Change
David Thomas stepped down as Non-executive director due to ill health; Peter Kiernan succeeds as Audit Committee Chair. |
+2.8% |
| 11 May 26 | Results | Half-year Results
H1 revenue up 1% to £147.1m; underlying PBT down 18% to £19.0m. Profit Improvement Plan launched targeting £10m savings in FY2027. |
−1.0% |
| 30 Apr 26 | Routine | Total Voting Rights | |
| 29 Apr 26 | Holding | Holding(s) in Company | |
| 31 Mar 26 | Routine | Total Voting Rights | |
| 24 Mar 26 | Holding | Holding(s) in Company | |
| 24 Mar 26 | Holding | Holding(s) in Company | |
| 20 Mar 26 | Holding | Holding(s) in Company | |
| 27 Feb 26 | Routine | Total Voting Rights | |
| 27 Feb 26 | Holding | Holding(s) in Company | |
| 24 Feb 26 | Holding | Holding(s) in Company | |
| 17 Feb 26 | Director dealing | Director/PDMR Shareholding | |
| 12 Feb 26 | Director dealing | Director/PDMR Shareholding | |
| 12 Feb 26 | Director dealing | Director/PDMR Shareholding | |
| 10 Feb 26 | Director dealing | Director/PDMR Shareholding | |
| 10 Feb 26 | Board change | Directorate Change
Peter Kiernan and Maria Antoniou appointed as non-executive directors; David Thomas to retire. |
+3.8% |
| 06 Feb 26 | Routine | Result of AGM | |
| 06 Feb 26 | Trading update | Q1 Trading Update
Q1 volumes down 4%, but YTD in line with prior year; full-year guidance unchanged. |
−3.4% |
| 30 Jan 26 | Routine | Total Voting Rights | |
| 28 Jan 26 | Holding | Holding(s) in Company | |
| 20 Jan 26 | Routine | Additional Listing | |
| 31 Dec 25 | Routine | Total Voting Rights | |
| 22 Dec 25 | Results | Annual Report
Victrex plc is an innovative world leader in high performance polymer solutions, whose products enable environmental and societal benefit in multiple end-markets. |
+0.3% |
| 18 Dec 25 | Director dealing | Director/PDMR Shareholding - Replacement | |
| 17 Dec 25 | Director dealing | Director/PDMR Shareholding | |
| 17 Dec 25 | Director dealing | Director/PDMR Shareholding | |
| 15 Dec 25 | Director dealing | Director/PDMR Shareholding | |
| 11 Dec 25 | Director dealing | Director/PDMR Shareholding | |
| 05 Dec 25 | Board change | Share purchase by incoming Director (incoming CEO)
Incoming CEO James Routh purchases 4,520 shares ahead of 1 January 2026 start date. |
+1.2% |
| 04 Dec 25 | Financial Calendar Update
Company updates financial calendar following preliminary results announcement. |
+1.1% | |
| 02 Dec 25 | Results | Final Results
FY 2025 revenue £292.7m up 1%, underlying PBT down 21% to £46.4m due to currency, sales mix and China plant costs. |
+7.7% |
| 01 Dec 25 | Routine | Block listing Interim Review | |
| 28 Nov 25 | Routine | Total Voting Rights | |
| 20 Nov 25 | Routine | Additional Listing | |
| 31 Oct 25 | Routine | Total Voting Rights | |
| 21 Oct 25 | Board change | CEO Succession update
Dr James Routh to become CEO on 1 January 2026, succeeding Jakob Sigurdsson. |
+0.5% |
Company filings. Not investment advice.